Navigate the complexities of phase 1 clinical trials in Chile with our step-by-step guide.
Introduction While Chile presents a fast-growing research environment for Phase 1 clinical trials, the complexities involved can pose significant challenges for MedTech and Biopharma companies. With advantages such as: A diverse patient population Streamlined regulatory processes Impressive retention rates Chile stands out as a strategic hub for early-stage studies. Despite the promising landscape, sponsors often find themselves grappling with regulatory complexities and the challenge of engaging patients effectively. How can sponsors effectively overcome these obstacles while maximizing the benefits of conducting trials in this promising market? Addressing these challenges is crucial for sponsors to fully capitalize on the advantages that Chile’s clinical trial landscape offers. Understand Phase 1 Clinical Trials in Chile Phase 1 clinical evaluations are crucial for determining the safety and efficacy of new medications and medical devices, yet many face challenges in navigatin…